Goldman Sachs and Morgan Stanley land on very different SpaceX price targets as Nasdaq-100 upgrade looms

SpaceX’s stock is entering a high-attention window for index-tracking flows, just as two major Wall Street banks indicated radically different fair-value estimates. Goldman Sachs set a $205 price target on SpaceX, while Morgan Stanley set a $300 target, a spread that the market commentary tied to about a $1 trillion difference in implied valuation.

The discrepancy comes at a time when passive investment products can mechanically increase demand for an included name. Nasdaq said SpaceX would join the Nasdaq-100 before the open on July 7, turning the standard index-rebalance cycle into a near-term focus for traders and portfolio managers.

In an estimate of potential passive inflows, JPMorgan calculated that Nasdaq-100 inclusion could bring $4.3 billion in index-related buying into the stock. TechStock²’s reporting also suggested that, in practice, index demand would be competing with the already heavy trading volume seen around the stock’s initial post-IPO period.

Market chatter around the split is being amplified by the stock’s recent trading range. TechStock² reported SpaceX last traded at $160.42, up roughly 19% from its $135 IPO price but still down about 29% from a June 16 peak. The same report framed the “usual forced-buying play” as potentially messy because of how much turnover had already occurred before the index move.

Both banks’ bullishness but different targets underscore a core problem in IPO-era coverage, where analysts must translate limited operating history and fast-changing industry assumptions into a valuation model. The $95 difference between the two targets is large enough that investors reading only the headline numbers could reasonably disagree on whether the stock is under or over valued, even if both firms are generally positive.

For Goldman Sachs, the $205 target represents a valuation view that is closer to the stock’s reported $160 area, while Morgan Stanley’s $300 target implies a much steeper upside path. The divergence matters less as an abstract debate and more because index and momentum traders often react to valuation narratives when liquidity is high and flows are expected.

Still, neither bank’s target tells the whole story. Price targets typically embed assumptions about future revenue growth, margins, competitive positioning, and broader capital markets conditions, and the public commentary does not outline those model inputs here. Until the underlying notes, assumptions, and any company-specific disclosures are reviewed, investors are left with two headline numbers rather than a transparent explanation of why they differ so much.

Looking ahead, the key thing to watch is how the stock trades through the Nasdaq-100 inclusion and whether post-rebalance demand absorbs the valuation gap implied by the targets. Analysts may also update their models if new information emerges about the company’s fundamentals or about how the index change actually impacts liquidity and supply.

Beyond the target spread, the market will likely focus on whether passive inflows materialize near the estimated $4.3 billion level, and how that compares with total trading activity during the rebalance window. If the stock’s reaction diverges from those flow expectations, it could prompt further recalibration of valuations by banks and other coverages.